Laboratory Historical Balance Sheet

LH Stock

USD 246.49 0.00 0.00%

Trend analysis of Laboratory of balance sheet accounts such as Total Current Liabilities of 3.9 B, Total Stockholder Equity of 9.5 B or Property Plant And Equipment Net of 3.5 B provides information on Laboratory's total assets, liabilities, and equity, which is the actual value of Laboratory to its prevalent stockholders. By breaking down trends over time using Laboratory balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Laboratory latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Laboratory is a good buy for the upcoming year.

Laboratory Inventory

573.08 Million

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

About Laboratory Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Laboratory at a specified time, usually calculated after every quarter, six months, or one year. Laboratory Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Laboratory and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Laboratory currently owns. An asset can also be divided into two categories, current and non-current.

Laboratory Balance Sheet Chart

As of now, Laboratory's Property Plant And Equipment Net is increasing as compared to previous years. The Laboratory's current Net Debt is estimated to increase to about 6.5 B, while Common Stock Shares Outstanding is projected to decrease to under 96 M.

Common Stock Shares Outstanding Total Assets Other Current Liab Total Current Liabilities

Add Fundamental

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of Laboratory assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Laboratory books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Laboratory balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Laboratory of are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Laboratory's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Laboratory current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	1.6B	676.5M	778.0M	484.1M
Total Assets	20.2B	16.7B	19.2B	20.2B

Other Current Liab Total Assets

Laboratory balance sheet Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Long Term Debt Total	Intangible Assets	Short Term Debt	Inventory	Property Plant And Equipment Gross	Common Stock	Common Stock Total Equity
Common Stock Shares Outstanding		0.58	0.47	0.52	0.47	0.41	0.65	0.49	0.49	0.32	0.62	0.15	0.32	0.49	0.75	0.12	0.11	0.66	0.42	0.74	0.65	0.29	0.32	0.22	0.94	0.89
Total Assets	0.58		0.51	0.73	0.98	0.95	0.93	0.95	0.92	0.58	0.99	0.55	0.58	0.95	0.9	0.57	0.38	0.98	0.95	0.94	0.86	0.15	0.85	0.78	0.56	0.31
Other Current Liab	0.47	0.51		0.69	0.53	0.43	0.42	0.57	0.43	0.12	0.51	0.26	0.12	0.42	0.42	0.62	-0.08	0.46	0.45	0.56	0.55	0.42	0.38	0.36	0.44	0.21
Total Current Liabilities	0.52	0.73	0.69		0.75	0.79	0.64	0.77	0.78	0.33	0.71	0.73	0.33	0.73	0.5	0.48	0.04	0.67	0.71	0.77	0.52	0.77	0.8	0.76	0.5	0.3
Total Stockholder Equity	0.47	0.98	0.53	0.75		0.96	0.85	0.99	0.92	0.6	0.96	0.64	0.6	0.96	0.81	0.63	0.28	0.92	0.98	0.87	0.8	0.18	0.9	0.85	0.48	0.18
Property Plant And Equipment Net	0.41	0.95	0.43	0.79	0.96		0.86	0.94	0.96	0.52	0.93	0.74	0.52	0.92	0.75	0.6	0.29	0.9	0.94	0.86	0.71	0.29	0.95	0.92	0.44	0.16
Net Debt	0.65	0.93	0.42	0.64	0.85	0.86		0.8	0.89	0.34	0.96	0.4	0.34	0.81	0.94	0.47	0.53	0.97	0.77	0.96	0.88	0.13	0.71	0.65	0.6	0.45
Retained Earnings	0.49	0.95	0.57	0.77	0.99	0.94	0.8		0.89	0.61	0.92	0.69	0.61	0.94	0.77	0.65	0.11	0.88	0.96	0.83	0.75	0.21	0.9	0.85	0.53	0.19
Accounts Payable	0.49	0.92	0.43	0.78	0.92	0.96	0.89	0.89		0.35	0.92	0.69	0.35	0.84	0.75	0.63	0.3	0.89	0.86	0.87	0.71	0.31	0.93	0.9	0.51	0.31
Cash	0.32	0.58	0.12	0.33	0.6	0.52	0.34	0.61	0.35		0.51	0.32	1.0	0.74	0.51	0.07	0.05	0.53	0.74	0.45	0.41	-0.04	0.51	0.41	0.37	0.1
Non Current Assets Total	0.62	0.99	0.51	0.71	0.96	0.93	0.96	0.92	0.92	0.51		0.51	0.51	0.92	0.93	0.55	0.42	0.99	0.9	0.96	0.89	0.14	0.82	0.74	0.59	0.36
Non Currrent Assets Other	0.15	0.55	0.26	0.73	0.64	0.74	0.4	0.69	0.69	0.32	0.51		0.32	0.62	0.25	0.41	-0.24	0.44	0.63	0.43	0.2	0.52	0.82	0.84	0.23	-0.04
Cash And Short Term Investments	0.32	0.58	0.12	0.33	0.6	0.52	0.34	0.61	0.35	1.0	0.51	0.32		0.74	0.51	0.07	0.05	0.53	0.74	0.45	0.41	-0.04	0.51	0.41	0.37	0.1
Net Receivables	0.49	0.95	0.42	0.73	0.96	0.92	0.81	0.94	0.84	0.74	0.92	0.62	0.74		0.8	0.42	0.29	0.9	0.97	0.85	0.77	0.19	0.86	0.77	0.48	0.19
Non Current Liabilities Total	0.75	0.9	0.42	0.5	0.81	0.75	0.94	0.77	0.75	0.51	0.93	0.25	0.51	0.8		0.38	0.49	0.96	0.76	0.93	0.91	-0.04	0.59	0.49	0.69	0.53
Other Current Assets	0.12	0.57	0.62	0.48	0.63	0.6	0.47	0.65	0.63	0.07	0.55	0.41	0.07	0.42	0.38		-0.01	0.49	0.58	0.44	0.43	0.08	0.63	0.66	0.21	-0.03
Other Stockholder Equity	0.11	0.38	-0.08	0.04	0.28	0.29	0.53	0.11	0.3	0.05	0.42	-0.24	0.05	0.29	0.49	-0.01		0.47	0.23	0.45	0.5	-0.19	0.12	0.1	-0.1	0.07
Total Liab	0.66	0.98	0.46	0.67	0.92	0.9	0.97	0.88	0.89	0.53	0.99	0.44	0.53	0.9	0.96	0.49	0.47		0.88	0.97	0.9	0.12	0.77	0.69	0.62	0.42
Total Current Assets	0.42	0.95	0.45	0.71	0.98	0.94	0.77	0.96	0.86	0.74	0.9	0.63	0.74	0.97	0.76	0.58	0.23	0.88		0.81	0.73	0.16	0.91	0.84	0.45	0.13
Short Long Term Debt Total	0.74	0.94	0.56	0.77	0.87	0.86	0.96	0.83	0.87	0.45	0.96	0.43	0.45	0.85	0.93	0.44	0.45	0.97	0.81		0.87	0.29	0.73	0.65	0.67	0.51
Intangible Assets	0.65	0.86	0.55	0.52	0.8	0.71	0.88	0.75	0.71	0.41	0.89	0.2	0.41	0.77	0.91	0.43	0.5	0.9	0.73	0.87		-0.02	0.55	0.46	0.57	0.34
Short Term Debt	0.29	0.15	0.42	0.77	0.18	0.29	0.13	0.21	0.31	-0.04	0.14	0.52	-0.04	0.19	-0.04	0.08	-0.19	0.12	0.16	0.29	-0.02		0.37	0.37	0.28	0.26
Inventory	0.32	0.85	0.38	0.8	0.9	0.95	0.71	0.9	0.93	0.51	0.82	0.82	0.51	0.86	0.59	0.63	0.12	0.77	0.91	0.73	0.55	0.37		0.96	0.4	0.12
Property Plant And Equipment Gross	0.22	0.78	0.36	0.76	0.85	0.92	0.65	0.85	0.9	0.41	0.74	0.84	0.41	0.77	0.49	0.66	0.1	0.69	0.84	0.65	0.46	0.37	0.96		0.29	0.03
Common Stock	0.94	0.56	0.44	0.5	0.48	0.44	0.6	0.53	0.51	0.37	0.59	0.23	0.37	0.48	0.69	0.21	-0.1	0.62	0.45	0.67	0.57	0.28	0.4	0.29		0.85
Common Stock Total Equity	0.89	0.31	0.21	0.3	0.18	0.16	0.45	0.19	0.31	0.1	0.36	-0.04	0.1	0.19	0.53	-0.03	0.07	0.42	0.13	0.51	0.34	0.26	0.12	0.03	0.85

Click cells to compare fundamentals

Laboratory Account Relationship Matchups

Laboratory balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Common Stock Shares Outstanding	98M	97.5M	91.6M	87.6M	100.7M	96.0M
Total Assets	20.1B	20.4B	20.2B	16.7B	19.2B	20.2B
Other Current Liab	784.2M	967M	1.6B	676.5M	778.0M	484.1M
Total Current Liabilities	2.6B	3.1B	2.8B	3.2B	3.7B	3.9B
Total Stockholder Equity	9.4B	10.3B	10.1B	7.9B	9.1B	9.5B
Property Plant And Equipment Net	2.7B	2.8B	3.0B	2.9B	3.3B	3.5B
Net Debt	5.4B	4.9B	5.9B	5.4B	6.2B	6.5B
Retained Earnings	9.4B	10.5B	10.6B	7.9B	9.1B	9.5B
Accounts Payable	638.9M	621.3M	852.2M	827.5M	951.6M	999.2M
Cash	1.3B	1.5B	430M	536.8M	617.3M	648.2M
Non Current Assets Total	14.9B	15.1B	15.5B	13.0B	14.9B	15.6B
Non Currrent Assets Other	410M	462.6M	432.7M	536.5M	617.0M	647.8M
Cash And Short Term Investments	1.3B	1.5B	430M	536.8M	617.3M	648.2M
Net Receivables	3.0B	3.0B	2.0B	2.1B	2.4B	2.5B
Liabilities And Stockholders Equity	20.1B	20.4B	20.2B	16.7B	19.2B	20.2B
Non Current Liabilities Total	7.6B	7.3B	7.0B	5.6B	6.5B	6.8B
Other Current Assets	364.8M	478.1M	2.4B	655.3M	753.6M	791.3M
Other Stockholder Equity	110.3M	(192M)	(493.2M)	38.4M	34.6M	32.8M
Total Liab	10.7B	10.1B	10.1B	8.8B	10.2B	10.7B
Total Current Assets	5.1B	5.3B	4.6B	3.8B	4.3B	4.5B
Short Long Term Debt Total	6.8B	6.3B	6.3B	6.0B	6.8B	7.2B
Intangible Assets	4.0B	3.7B	3.9B	3.3B	3.8B	2.0B
Short Term Debt	774.1M	396.5M	471.1M	1.2B	1.3B	1.4B
Inventory	423.2M	401.4M	470.6M	474.6M	545.8M	573.1M
Property Plant And Equipment Gross	2.7B	5.2B	5.7B	5.8B	6.7B	7.0B
Accumulated Other Comprehensive Income	(161.9M)	(192M)	(493.2M)	(59.3M)	(53.4M)	(56.0M)
Other Liab	1.3B	1.4B	1.2B	1.1B	1.2B	702.7M
Other Assets	356.5M	350.9M	484.2M	440.3M	506.3M	531.7M
Long Term Debt	5.4B	5.4B	5.0B	4.1B	4.7B	3.1B
Property Plant Equipment	2.7B	2.8B	2.8B	3.0B	3.4B	3.6B
Good Will	7.8B	8.0B	8.1B	6.1B	7.1B	4.4B
Current Deferred Revenue	506.5M	558.5M	582.1M	421.7M	485.0M	509.2M
Net Tangible Assets	(4.3B)	(2.4B)	(1.4B)	(2.0B)	(1.8B)	(1.9B)
Long Term Debt Total	5.9B	5.5B	5.5B	5.1B	5.9B	4.8B

Currently Active Assets on Macroaxis

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications
DIA	SPDR Dow Jones
SPY	SPDR SP 500

How To Invest In Laboratory

Details

Is Laboratory Stock a good investment?

Details

What is Laboratory's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.05)

Dividend Share

2.88

Earnings Share

8.85

Revenue Per Share

155.052

Quarterly Revenue Growth

0.098

The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Laboratory Historical Balance Sheet

Laboratory Inventory

573.08 Million

About Laboratory Balance Sheet Analysis

Laboratory Balance Sheet Chart

Common Stock Shares Outstanding

Total Assets

Total Current Liabilities

Laboratory balance sheet Correlations

Laboratory Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Laboratory balance sheet Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Non Current Assets Total	+ 0.99	Total Assets
Retained Earnings	+ 0.99	Total Stockholder Equity
Total Liab	+ 0.99	Non Current Assets Total
Total Stockholder Equity	+ 0.98	Total Assets
Total Liab	+ 0.98	Total Assets

Other Stockholder Equity	- 0.24	Non Currrent Assets Other
Short Term Debt	- 0.19	Other Stockholder Equity
Common Stock	- 0.1	Other Stockholder Equity
Other Stockholder Equity	- 0.08	Other Current Liab
Short Term Debt	- 0.04	Non Current Liabilities Total
Short Term Debt	- 0.04	Cash And Short Term Investments